Market Tracker

05/03 6:22am ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.34
Delayed Data
As of May 02
 +0.08 / +3.54%
Today’s Change
1.13
Today|||52-Week Range
4.37
-28.66%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close2.26
Today’s open2.28
Day’s range2.25 - 2.36
Volume65,011
Average volume (3 months)159,334
Market cap$99.0M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc0.000.00%
NNVCNanoViricides Inc+0.08+4.71%
XOMAXOMA Corp-0.01-0.93%
CORICorium International...+0.27+6.03%
Data as of 05/02/2016

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts